13D Filing: Aisling Capital III LP and Transenterix Inc. (TRXC)

CUSIP No. 89366M102

SCHEDULE 13D/A

Page 11 of 12

Item 6.

Contract, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.

No Material Change.

Item 7.

Material to Be Filed as Exhibits.

The following documents are filed as exhibits hereto:

Exhibit 1:		Statement Appointing Designated Filer dated as of September 13, 2013, as required by Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended (incorporated herein by reference to Exhibit 1 to Schedule 13D filed by the Reporting Persons on September 13, 2013).

Exhibit 2:		Underwriting Agreement dated as of April 28, 2017, by and between the Issuer and Stifel, Nicolaus & Company, Incorporated (incorporated by reference to Exhibit 1.1 to the Issuer’s Current Report on Form 8-K filed with the SEC on April 28, 2017).

Exhibit 3:		Form of Series A Warrant (incorporated by reference to Exhibit 4.1 to the Issuer’s Current Report on Form 8-K filed with the SEC on April 28, 2017).

Exhibit 4:		Form of Series B Warrant (incorporated by reference to Exhibit 4.2 to the Issuer’s Current Report on Form 8-K filed with the SEC on April 28, 2017).

Page 11 of 12 – SEC Filing